EUVIMEDEUVIMED entdecken
Open Access

Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis

Arnaud S Girard iD, Audrey Paulin iD, Hasanga D Manikpurage iD, Emma Lajeunesse, Marie-Annick Clavel iD, Philippe Pibarot iD, John H Krege iD, Patrick Mathieu iD, Sébastien Thériault iD, Benoit J Arsenault iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.038955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Arnaud S Girard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval Québec QC Canada. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Lipoprotein(a), Aortic Valve, Calcinosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Lp(a) (lipoprotein(a)) is an independent risk factor for calcific aortic valve stenosis (CAVS). Whether patients with CAVS and high Lp(a) levels are at higher risk of valvular or cardiovascular events is unknown. The aim of this study is to determine whether higher Lp(a) levels are associated with valvular and cardiovascular outcomes in patients with CAVS. Methods and Results We identified 1962 patients from the UK Biobank with an electronic health record or self‐reported CAVS diagnosis but who did not previously undergo aortic valve replacement (AVR) and had a minimal follow‐up time of 2.5 years. Cox proportional hazard regression was used to evaluate the effect of Lp(a) on AVR, AVR or cardiac death, and valvular or cardiovascular events (AVR, cardiac death, myocardial infarction, stroke, heart failure, or coronary artery bypass grafting). The maximal follow‐up time was set to 5 years. During the follow‐up, 198 patients underwent AVR, 260 had AVR or cardiac death, and 435 had at least 1 valvular or cardiovascular event. Patients with Lp(a) levels ≥125 versus

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisLipoprotein(a)Aortic ValveCalcinosisHumansFemaleMaleAgedMiddle AgedRisk FactorsBiomarkersRisk AssessmentUnited KingdomAged, 80 and overTime Factors

Stichwörter der Autor:innen

aortic valve replacementcalcific aortic valve stenosisheart failurelipoprotein(a)myocardial infarctionstroke

Substanzen

Lipoprotein(a)BiomarkersLPA protein, human

Autor:innen und Institutionen

  • Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval Québec QC Canada.
  • Department of Medicine, Faculty of Medicine Université Laval Québec QC Canada.
  • Eli Lilly Indianapolis IN USA.
  • Department of Surgery, Faculty of Medicine Université Laval Québec QC Canada.
  • Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine Université Laval Québec QC Canada.

ORCID-Profile: Arnaud S Girard, Audrey Paulin, Hasanga D Manikpurage, Marie-Annick Clavel, Philippe Pibarot, John H Krege, Patrick Mathieu, Sébastien Thériault, Benoit J Arsenault

Zitieren

APA

Girard, A. S., Paulin, A., Manikpurage, H. D., Lajeunesse, E., Clavel, M. A., Pibarot, P., Krege, J. H., Mathieu, P., Thériault, S., & Arsenault, B. J. (2025). Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.038955

Vancouver

Girard AS, Paulin A, Manikpurage HD, Lajeunesse E, Clavel MA, Pibarot P, et al. Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.038955

BibTeX
@article{Girard2025,
  author = {Girard, Arnaud S and Paulin, Audrey and Manikpurage, Hasanga D and Lajeunesse, Emma and Clavel, Marie-Annick and Pibarot, Philippe and Krege, John H and Mathieu, Patrick and Thériault, Sébastien and Arsenault, Benoit J},
  title = {Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.038955}
}
Kostenlos starten →